Financials
- Market Capitalization 20.27 M
- Employee 8
- Founded 1996
- CEO N/A
- Website www.neuphoriatx.com
- Headquarter Australia
- FIGI BBG01RFZ8658
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.42
ratio cours/chiffre d'affaires
207.27
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4542 | MRKR Marker Therapeutics, Inc. - Common Stock | 1.25 USD | -3.85% | -16.11% | +0.81% | +47.06% | 20.84 M USD | ||
| 4547 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 12.61 USD | -0.16% | -14.04% | -0.32% | +115.56% | 20.41 M USD | ||
| 4557 | ENLV Enlivex Ltd. - Ordinary Shares | 1.25 USD | -2.34% | -17.22% | -44.44% | +20.19% | 19.78 M USD | ||
| 4558 | AKTX Akari Therapeutics Plc - American Depositary Shares | 10.15 USD | -2.12% | +5.73% | +35.15% | +1392.65% | 19.76 M USD |